Skip to main content

Want a detailed portfolio tracker?

Durect (DRRX) Total Debt (2010 - 2025)

Durect (DRRX) total debt from Dec 31, 2010 to Jun 30, 2025. The current Durect (DRRX) total debt is $9M. You can adjust inflation or export chart.

Total Debt

Total Debt

Durect (DRRX) Total Debt CAGR table

PeriodCAGR
1 Year TTM-59.44%
3 Years TTM-28.03%
5 Years TTM-26.01%
10 Years TTM-8.45%
All Time TTM-7.42%

Annual Total Debt change of Durect (DRRX)

YearTotal DebtChange
2024$9.22M
-69.68%
2023$30M
-13.41%
2022$35M
+2.66%
2021$34M
-3.72%
2020$36M
-43.75%
2019$63M
+110.53%
2018$30M
-5.15%
2017$32M
-1.68%
2016$32M
+0.88%
2015$32M
+1.01%
2014$32M
+212.57%
2013$10M
+5.21%
2012$9.60M
-79.00%
2011$46M
-13.85%
2010$53M
N/A

Comparison Durect (DRRX) total debt with competitors

Durect (DRRX) total debt is $9.00M.

TickerNameTotal DebtUpside
CABRCaring Brands Inc$384473.00-95.73%
RGCRegencell Bioscience Holdings Ltd$895308.00-90.05%
APUSApimeds Pharmaceuticals US Inc$1.09M-87.90%
INMInMed Pharmaceuticals Inc$2.24M-75.09%
PRFXPRF Technologies Ltd$2.71M-69.91%
YCBDcbdMD Inc$2.97M-67.02%
IXHLIncannex Healthcare Ltd$5.05M-43.90%
GELSGelteq Ltd$5.67M-36.99%
SXTCChina SXT Pharmaceuticals Inc$6.22M-30.85%
SBFMSunshine Biopharma Inc$6.41M-28.74%
CRDLCardiol Therapeutics Inc - Class A$7.22M-19.76%
CPHIChina Pharma Holdings Inc$8.12M-9.78%
SHPHShuttle Pharmaceuticals Holdings Inc$8.46M-5.97%
BGMQilian International Holding Group Ltd - Class A$8.91M-1.00%
SNOASonoma Pharmaceuticals Inc$10.19M+13.23%
TXMDTherapeuticsMD Inc$10.61M+17.87%
TLPHTalphera Inc$11.68M+29.74%
EVOKEvoke Pharma Inc$12.29M+36.52%
BIOABioAge Labs Inc$18.53M+105.92%
BFRIBiofrontera Inc$18.72M+107.97%
AMLXAmylyx Pharmaceuticals Inc$20.44M+127.13%
RMTIRockwell Medical Inc$21.57M+139.62%
IMCCIM Cannabis Corp$28.80M+220.05%
TKNOAlpha Teknova Inc$33.73M+274.81%
SCYXScynexis Inc$36.32M+303.54%
CRONCronos Group Inc$48.30M+436.61%
CPIXCumberland Pharmaceuticals Inc$49.69M+452.13%
DERMJourney Medical Corp$60.70M+574.48%
CTORCitius Oncology Inc$65.43M+627.00%
ETONEton Pharmaceuticals Inc$67.09M+645.50%
SIGASIGA Technologies Inc$67.77M+652.96%
AYTUAytu BioPharma Inc$100.72M+1019.12%
AVDLAvadel Pharmaceuticals plc$101.22M+1024.70%
DCPHDeciphera Pharmaceuticals Inc$104.88M+1065.31%
KMDAKamada Ltd$123.63M+1273.71%
ZYBTZhengye Biotechnology Holding Ltd$129.76M+1341.74%
ASRTAssertio Holdings Inc$135.67M+1407.41%
ORGOOrganogenesis Holdings Inc - Class A$138.65M+1440.50%
BTAIBioXcel Therapeutics Inc$139.57M+1450.76%
OGIOrganiGram Holdings Inc$149.89M+1565.40%
AQSTAquestive Therapeutics Inc$175.18M+1846.43%
LFCRLifecore Biomedical Inc$204.72M+2174.68%
ACBAurora Cannabis Inc$207.47M+2205.18%
KNSAKiniksa Pharmaceuticals International plc. - Class A$219.59M+2339.92%
EOLSEvolus Inc$249.43M+2671.41%
LQDALiquidia Corp$292.95M+3155.04%
INCRINC Research Holdings Inc$294.19M+3168.83%
AKBAAkebia Therapeutics Inc$335.14M+3623.83%
CGCCanopy Growth Corporation$348.02M+3766.88%
XERSXeris Biopharma Holdings Inc$379.00M+4111.13%
HROWHarrow Inc$391.19M+4246.58%
DVAXDynavax Technologies Corp$412.37M+4481.87%
SUPNSupernus Pharmaceuticals Inc$423.92M+4610.22%
HCMHUTCHMED (China) Ltd$534.02M+5833.52%
TLRYTilray Brands Inc$549.12M+6001.28%
PCRXPacira BioSciences Inc$554.64M+6062.68%
ESPREsperion Therapeutics Inc$770.46M+8460.67%
EBSEmergent Biosolutions Inc$797.30M+8758.89%
UTHRUnited Therapeutics Corp$813.10M+8934.44%
ANIPANI Pharmaceuticals Inc$859.67M+9451.89%
AMPHAmphastar Pharmaceuticals Inc$874.77M+9619.68%
EVOEvotec SE$941.17M+10357.48%
BCRXBiocryst Pharmaceuticals Inc$1.02B+11221.06%
PAHCPhibro Animal Health Corp - Class A$1.08B+11936.57%
LNTHLantheus Holdings Inc$1.13B+12503.32%
COLLCollegium Pharmaceutical Inc$1.34B+14783.70%
INDVIndivior Plc$1.34B+14800.00%
NBIXNeurocrine Biosciences Inc$1.50B+16553.33%
PBHPrestige Consumer Healthcare Inc$1.61B+17753.30%
ALVOAlvotech$1.70B+18827.56%
HIMSHims & Hers Health Inc - Class A$1.82B+20131.96%
ALKSAlkermes plc$2.51B+27750.50%
PRGOPerrigo Company plc$5.48B+60838.89%
ELANElanco Animal Health Inc$6.72B+74588.89%
ZTSZoetis Inc - Class A$11.92B+132355.56%
UPCUniverse Pharmaceuticals Inc$13.17B+146277.00%
HLNHaleon plc$16.12B+178984.67%
VTRSViatris Inc$22.18B+246310.00%
BHCBausch Health Companies Inc$25.58B+284122.22%
TEVATeva- Pharmaceutical Industries Ltd$31.81B+353333.33%
RDYDr. Reddy`s Laboratories Ltd$194.95B+2166028.14%
TAKTakeda Pharmaceutical Company$597.16B+6635000.00%